Plus   Neg

Eastern Bankshares, Century Bancorp To Merge In $642 Mln Deal

Eastern Bankshares Inc. (EBC) and Century Bancorp Inc. (CNBKA) said that they have entered into a all-cash merger agreement with an aggregate transaction value of $642 million.

The transaction comes less than six months after Eastern's initial public offering that raised approximately $1.7 billion in equity capital.

As per the terms of the deal, Century shareholders will receive $115.28 in cash for each share of Century Bancorp,'s common stock.

The acquisition is expected to close in the fourth quarter of 2021.

Eastern expects the transaction to be approximately 55% accretive to earnings on a fully synergized basis and to have an IRR of about 17%. Eastern will fund the purchase price with cash on hand from its balance sheet.

Eastern also announced a 33% increase to its quarterly dividend to $0.08 per share as part of its overall capital management strategy.

Eastern declared a quarterly cash dividend of $0.08 per common share, payable on June 15, 2021, to shareholders of record as of the close of business on June 3, 2021.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Guan's Mushroom Co. is recalling all cases of its 200g/7.05-ounce packages of Enoki Mushroom citing the potential to be contaminated with Listeria monocytogenes, the U.S. Food and Drug Administration said. The recalled Enoki is a product of China and comes in a clear plastic package with the description "Enoki Mushroom" in English, Korean and French, and Guan's logo in the front. Shares of Roche were gaining around 2 percent in Swiss trading after the drug major reported Wednesday a 3 percent rise in first-quarter sales at constant currency basis mainly driven by strong growth in Diagnostics Division. Sales, on a reported basis, edged down 1 percent mainly with significant impact from biosimilars. Looking ahead for fiscal 2021, the company continues to expect sales to grow Church & Dwight Co., Inc. is recalling select vitafusion gummy products due to isolated manufacturing issue, the U.S. Food and Drug Administration said. The recall was initiated after the company's investigation of two consumer reports identified the possible presence of a metallic mesh material in product lots manufactured in a four-day period between October 29 and November 3, 2020.
Follow RTT